Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds Love Splunk Inc (SPLK)?

Page 1 of 2

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile gigantic failures like hedge funds’ recent losses in Valeant. Let’s take a closer look at what the funds we track think about Splunk Inc (NASDAQ:SPLK) in this article.

Splunk Inc (NASDAQ:SPLK) shares haven’t seen a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 23 hedge funds’ portfolios at the end of the third quarter of 2015. At the end of this article we will also compare SPLK to other stocks including Pinnacle West Capital Corporation (NYSE:PNW), Aramark (NYSE:ARMK), and DENTSPLY International Inc. (NASDAQ:XRAY) to get a better sense of its popularity.

Follow Splunk Inc (NASDAQ:SPLK)
Trade (NASDAQ:SPLK) Now!

Now, we’re going to take a look at the new action regarding Splunk Inc (NASDAQ:SPLK).

Hedge fund activity in Splunk Inc (NASDAQ:SPLK)

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Criterion Capital, managed by Christopher Lord, holds the number one position in Splunk Inc (NASDAQ:SPLK). Criterion Capital has a $92.8 million position in the stock, comprising 3.2% of its 13F portfolio. The second most bullish fund manager is Columbus Circle Investors, which holds a $77.2 million position; the fund has 0.6% of its 13F portfolio invested in the stock. Some other professional money managers that hold long positions consist of Chase Coleman’s Tiger Global Management LLC, Ken Griffin’s Citadel Investment Group and Brian Ashford-Russell and Tim Woolley’s Polar Capital.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!